Position in NRIX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,500,808
+$3,232,273 QoQ
Shares Held
185,524
+126.7% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 210 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. NRIX ranks #56 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
336,990 | $167,393,033 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
230,151 | $143,508,345 | |
| 3 | RPRX |
Royalty Pharma plc
|
1,694,250 | $94,996,587 | |
| 4 | INCY |
Incyte Corp
|
425,616 | $48,247,822 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
158,228 | $47,631,369 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
783,148 | $44,811,725 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
120,304 | $38,026,888 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
418,025 | $34,098,295 |
All Filings in NRIX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,500,808 | 185,524 | Shares | Other | 2026-08-06 | |
| 2026-03-31 | $1,268,535 | 81,841 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,204,250 | 63,482 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $558,427 | 60,436 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $28,634 | 2,514 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,541,285 | 129,738 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $673,434 | 35,745 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $16,357 | 728 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $72,480 | 3,473 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $787,067 | 53,542 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $314,739 | 30,498 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $239,595 | 30,483 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $355,204 | 35,556 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $325,682 | 36,676 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $264,496 | 24,089 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $11,453 | 879 | Shares | Defined | 2022-11-04 | |
| 2021-06-30 | $152,520 | 5,749 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $178,736 | 5,749 | Shares | Sole | 2021-05-10 | |
| No filing history on record for this holder in this stock. | ||||||